Skip to content

Asan Medical Center CCTA Registry

Assessment of Coronary Artery Disease in Asymptomatic Population Undergoing Coronary Computed Tomography Angiography: A Single Center, Prospective Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06036901
Enrollment
6343
Registered
2023-09-14
Start date
2007-01-01
Completion date
2022-12-31
Last updated
2023-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Computed Tomography, Coronary Artery Disease, Risk Factor

Brief summary

A total of 9269 adults who received CCTA scans for coronary disease evaluation during a general medical checkup at the Health Screening and Promotion Center in Asan Medical Center, Seoul, Korea between January 2007 and December 2011 were initially selected. All participants were provided with information about the potential benefits and risks of CCTA and made the decision to undergo the procedure at their own expense. They were also informed that their clinical and radiological data would be used for this study and gave their consent. Of these individuals, 7129 agreed to participate, and 6343 were enrolled in this CCTA registry.

Interventions

DIAGNOSTIC_TESTCoronary CT

Coronary CT evaluation

Sponsors

CardioVascular Research Foundation, Korea
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Exclusion criteria

1. a previous history of angina or myocardial infarction; 2. abnormal rest electrocardiographic results, i.e., pathological Qwaves, ischemic ST segments or T wave changes, or left bundle-branch blocks; 3. insufficient medical records; 4. structural heart diseases; 5. a prior history of open heart surgery or percutaneous coronary intervention; 6. a previous cardiac procedure; or 7. renal insufficiency (creatinine N1.5 mg/dL)

Design outcomes

Primary

MeasureTime frameDescription
The prevalence of CAD5 yearsDiameter stenosis \>50% in any coronary artery by coronary CT angiography

Secondary

MeasureTime frameDescription
All cause mortality5 years
cardiovascular mortality5 yearsany death caused by a cardiovascular problem or if there was no identified cause of death
myocardial infarction5 yearsNumber of participants with an increase in cardiac enzyme above the upper reference limit with ischemic symptoms or signs.
Revascularization5 yearsNumber of participants with any percutaneous or surgical revascularization procedure during follow-up.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026